Case Study: Beverly Michalos's Journey with Parkinson's
Condition:
Stage 5 Young Onset
Parkinson’s.
Intervention:
Weekly
20-minute KineDek sessions:
- Bev started KineDek sessions on 13
October 2022.
- Initial sessions were seated. Early symptom
changes included better sleep, decreased levels of pain and neuropathy, and
decreased dyskinesia and tremors.
- As sessions progressed other improvements
included relaxation of facial muscles and improved bowel function.
- Significant improvements in strength and muscle
development were observed throughout this period. Improved response to
medication was also communicated.
- Except for a vacation and a period of influenza, the weekly schedule was maintained.
- It is observed that if a session is missed, there is a perceptible reversal of symptoms, particularly regarding pain, sleep and neuropathy.
Outcome:
Overall, there has been significant improvement in functionality, accompanied by:
- Improved sleep quality
- Enhanced digestive function
- Better response to medication
- Increased strength and stamina for everyday activities
- No longer requiring the use of a wheelchair, which is typically necessary at Stage 4 Parkinson's
- No apparent signs of dementia, which is typically present at Stage 5
Notably, her facial expression has transformed from a fixed, pained, or frightened look (a marker of disease severity) to completely normal and natural expressions, maintaining this progress for over two years. These advancements demonstrate a remarkable reversal of Parkinson's symptoms, defying expectations at this stage of the disease.
in the past 20 months (as of October 2022 to June 2024) she is showing no cognitive decline, and indeed has shown significant cognitive improvement in the first month since starting session. Since then show has remained stable without any apparent improved cognition either.
Notably, her facial expression has undergone a remarkable transformation, changing from a fixed, pained, or frightened look - a marker of disease severity - to completely normal and natural expressions. This progress has been maintained since, defying expectations for Parkinson's disease progression. Furthermore, despite being in stage 5, she has shown no cognitive decline over the past 20 months since sessions commenced (from October 2022 to June 2024). In fact, she experienced significant cognitive improvement in the first month of treatment, which has since remained stable with no further apparent decline or improvement.
Audio Testimony
[From WhatsApp voice messages received]
Disclaimer:
The above has been feedback from the personal experiences of an individual who have used the KineDek. These accounts are individual to each person and are not to be taken as a guarantee that others will experience the same outcomes. The KineDek is not presented as a cure for any condition. Rather, it serves as an enabler for exercise, particularly for those who may otherwise find traditional forms of exercise challenging or painful. Through its AI-enabled Compensating Resistance Technology (AI-CRT), the KineDek allows individuals to engage in physical activity without perceived pain, strain, or subsequent inflammation. Consequently, users can enjoy the well-documented benefits of "Exercise as Medicine." If you have a serious medical condition, always consult with a healthcare professional before starting any new exercise regimen.
All cases presented can be verified on request.
KINEDEK CASES
